Target intelligence / Profile preview

Parasitic flatworm transient receptor potential melastatin ion channel (TRPM PZQ)

Target
TRPM PZQ
Molecular classification
Ion channel, Transient receptor potential channel, Transient receptor potential melastatin channel
01

Overview

The parasitic flatworm transient receptor potential melastatin ion channel (commonly known as TRPM PZQ) is a large, non-selective cation channel present in trematodes and cestodes responsible for major human and veterinary parasitic infections such as schistosomiasis[1][2][4][5]. It is gated by both physical cues (membrane stretch) and chemical ligands, most notably the anthelmintic drug praziquantel, which binds to a hydrophobic pocket in the channel's voltage sensor–like domain. Activation of TRPM PZQ by praziquantel causes calcium influx, membrane depolarization, and sustained muscle contraction, leading to parasite paralysis and clearance from the host. This channel is absent or divergent in flukes insensitive to praziquantel, and specific sequence features of TRPM PZQ determine drug sensitivity[2][3][4][5]. TRPM PZQ is considered a validated and appealing therapeutic target for anti-parasitic drug development due to its essential role in parasite physiology, high conservation among sensitive flatworms, and divergence from mammalian homologs[1][2][6].

Other names
TRPM PZQSchistosoma mansoni TRPM PZQ (Sm.TRPM PZQ)schistosome TRPM PZQparasitic flatworm TRPM ion channel
02

Mechanism of action

Activation by praziquantel causes calcium influx, membrane depolarization, spastic muscle contraction, and parasite paralysis leading to immunological clearance[2][3][4].

03

Biological functions

Calcium entryMembrane depolarizationSignal transductionMuscle contraction
04

Disease associations

InfectionTrematodiases (including schistosomiasis, opisthorchiasis, clonorchiasis)
05

Safety considerations

Potential for praziquantel resistance via TRPM PZQ sequence variation[5]Non-selectivity between flatworm and vertebrate ion channels may be a theoretical concern for drug design, but current drugs (PZQ) show parasite selectivity[2][3].
06

Interacting drugs

Praziquantel

1 more in the full profile.

07

Biomarkers

TRPM PZQ gene/protein as a marker for praziquantel susceptibility in parasitic flatworms[4][5].

Beyond the preview

Go deeper on Parasitic flatworm transient receptor potential melastatin ion channel (TRPM PZQ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasitic flatworm transient receptor potential melastatin ion channel (TRPM PZQ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call